http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104003913-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-27
filingDate 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a84cb7c344f3c2237ea2d760190473a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a981b3acc0f9f1e5471c494fc0a3048d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d2ffae640b00730dc118d9e457b5a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c101cf3b3b22773db597643f874f7707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35993bc39faef1f7ff44ad14bb394635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_113b813115dcffafee96a2761fbbbd3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38604b2f5556dfc744446779a738423d
publicationDate 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104003913-A
titleOfInvention E-3, the preparation method of 4-dihydroxystyryl sulfonamide and sulfonate compound and its application as neuroprotective agent
abstract The application relates to the general formula E-3,4-dihydroxystyryl sulfonamide and the use of sulfonate compound I in the preparation of neuroprotective drugs or pharmaceutical compositions for neurodegenerative diseases, the definition of each group in the formula As stated in the claims. The invention also relates to processes for the preparation of said compounds. General formula I (wherein X is N or O)
priorityDate 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467625110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466082731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID407038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415958328

Total number of triples: 34.